APA (7th ed.) Citation

Kyriakopoulos, C. E., Chen, Y., Carducci, M. A., Liu, G., Jarrard, D. F., Hahn, N. M., . . . Sweeney, C. J. (2018). Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial. Journal of clinical oncology, 36(11), 1080-1087. https://doi.org/10.1200/JCO.2017.75.3657

Chicago Style (17th ed.) Citation

Kyriakopoulos, Christos E., et al. "Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial." Journal of Clinical Oncology 36, no. 11 (2018): 1080-1087. https://doi.org/10.1200/JCO.2017.75.3657.

MLA (9th ed.) Citation

Kyriakopoulos, Christos E., et al. "Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial." Journal of Clinical Oncology, vol. 36, no. 11, 2018, pp. 1080-1087, https://doi.org/10.1200/JCO.2017.75.3657.